Regression of cutaneous warts in a patient with WILD syndrome following recombinant quadrivalent human papillomavirus vaccination

Archives of Dermatology

Volumn 146, Issue 10, 2010, Pages 1196-1197

  Kreuter, Alexander ^a   Waterboer, Tim ^b   Wieland, Ulrike ^c  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT VACCINE; WART VIRUS VACCINE;

ADULT; ANOGENITAL DYSPLASIA; ANUS DISEASE; CASE REPORT; CLINICAL FEATURE; GENITAL SYSTEM DISEASE; HAND; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; LETTER; LYMPHEDEMA; MALE; PRIORITY JOURNAL; SYNDROME; TREATMENT RESPONSE; VACCINATION; VIRAL SKIN DISEASE; VIRUS INFECTION; VIRUS TYPING; WART VIRUS; WILD SYNDROME; ANAL CANAL; CELLULAR IMMUNITY; COMPLICATION; FEMALE; FEMALE GENITAL SYSTEM; IMMUNE DEFICIENCY; MULTIPLE MALFORMATION SYNDROME; PAPILLOMAVIRUS INFECTION; REMISSION; WARTS;

ABNORMALITIES, MULTIPLE; ADULT; ANAL CANAL; FEMALE; GENITALIA, FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC DEFICIENCY SYNDROMES; LYMPHEDEMA; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; REMISSION INDUCTION; SYNDROME; VACCINES, SYNTHETIC; WARTS;

EID: 77958184929     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2010.290     Document Type: Letter

References (5)

1. Venugopal SS, Murrell DF. Recalcitrant cutaneous warts treated with recombinant quadrivalent human papillomavirus vaccine (types 6, 11, 16, and 18) in a developmentally delayed, 31-year-old white man. Arch Dermatol. 2010;146(5):475-477.
2. Kreuter A, Hochdorfer B, Brockmeyer NH, Altmeyer P, Pfister H, Wieland U; Competence Network HIV/AIDS. A human papillomavirus-associated disease with disseminated warts, depressed cell-mediated immunity, primary lymphedema, and anogenital dysplasia: WILD syndrome. Arch Dermatol. 2008;144(3):366-372.
3. Hildesheim A, Herrero R, Wacholder S, et al; Costa Rican HPV Vaccine Trial Group. Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA. 2007;298(7):743-753.
4. Waterboer T, Sehr P, Michael KM, et al. Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem. 2005;51(10):1845-1853.
5. Kenter GG, Welters MJ, Valentijn AR, et al. Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N Engl J Med. 2009;361(19):1838-1847.